FDA Grants Fast Track Designation to Milvexian for Multiple

The proposed indications for milvexian include stroke prevention after an acute ischemic stroke or high-risk transient ischemic attack; recent acute coronary syndrome; and atrial fibrillation.

Related Keywords

, Robert Harrington , Arthurl Bloomfield , Janssen Research Development , Department Of Medicine At Stanford University , Bristol Myers Squibb , Janssen Pharmaceutical , Stanford University , Janssen Research ,